Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Matthew Mark Trims His Stake In SunCoke Energy Inc. (SXC) ~ Will SunCoke Get Back On Track?

Page 1 of 2

Matthew Mark’s Jet Capital Investors has filed a Schedule 13D with the Securities and Exchange Commission indicating it has trimmed its stake in SunCoke Energy Inc. (NYSE:SXC) by 2.36 million shares since its most recent 13F filing. According to this freshly-amended filing, Jet Capital Investors currently owns 1.76 million shares in the producer of metallurgical coke, which represents 2.7% of the company’s outstanding common stock. This move might come as a result of the fund’s discontent about the lack of action by the company in creating shareholder value in spite of clear alternatives within management’s control. In February, Jet Capital Investors sent a letter to SunCoke’s management that points out some strategic actions that the company could implement in order to create shareholder value; however, the company’s response was continued inaction, which led to a further decline in its share price (see more details).

Mining Tunnel Coal

Jet Capital Investors LP is a New York-based hedge fund established by Matthew Mark in 2002. The investment firm is primarily implementing merger arbitrage, capital structure arbitrage, and event-oriented trading strategies in investing its capital in the public equity and fixed income markets around the world. Jet Capital Investors currently has $2.4 billion in assets under management, which grants it the title of a large investment firm with over $1 billion in assets. The public equity portfolio managed by Matthew Mark and his team consists of nearly 50 active positions as of March 31, while the market value of these positions at the time came to $3.32 billion. At the same time, the hedge fund manages a relatively diversified public equity portfolio, with its holdings dispersed across the following sectors: 29.68% in the services sector, 23.47% in the utilities sector, and 10.87% and 7.56% in the healthcare and capital goods sectors, respectively.

Matthew Mark
Matthew Mark
Jet Capital Investors

We track hedge funds and prominent investors because our research has shown that historically their stock picks delivered superior risk-adjusted returns. This is especially true in the small-cap space. The 50 most popular large-cap stocks among hedge funds had a monthly alpha of about 6 basis points per month between 1999 and 2012; however the 15 most popular small-cap stocks delivered a monthly alpha of 80 basis points during the same period. This means investors would have generated 10 percentage points of alpha per year simply by imitating hedge funds’ top 15 small-cap ideas. We have been tracking the performance of these stocks since the end of August 2012 in real time and these stocks beat the market by 801percentage points (139.7% return vs. S&P 500’s 58.7% gain) over the last 34 months (see the details here).

SunCoke Energy Inc. (NYSE:SXC) is a producer and supplier of high-quality coke to the integrated steel industry under long-term take-or-pay coke contracts. The company has gained the position of being the largest independent producer of metallurgical coke in both North America and South America, operating in this industry for over 45 years. SunCoke Energy mines metallurgical coal in underground and surface mines and operates a number of coke making facilities in the U.S. and Brazil. In addition to that, SunCoke Energy is the sponsor of SunCoke Energy Partners L.P. (NYSE:SXCP), a publicly traded master limited partnership, with 2% general partner interest, 56% limited partnership interest, and all of the incentive distribution rights.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!